Study shows HPV vaccine effective in protecting against some forms of cancer

A vaccine to protect against some cancers has been shown to be very effective. The human papillomavirus vaccine recommended for pre-teens has been linked to a greater than 80% decrease in infections. A Kansas City doctor says that’s huge when it comes to saving lives. The HPV vaccine was approved 15 years ago. Now a 10-year study shows the effect it has on the protection of children into adulthood. It reduces the transmission of the virus by as much as 88%. A virus linked to cervical cancer in women and throat cancer in men. “I think people have really realized that the vaccine is safe, that the protection is phenomenal and that the side effects with this vaccine are really very minimal,” said Dr. Angela Myers, director of infectious diseases at Children’s Mercy Hospital. The HPV vaccine is recommended for boys and girls at the age of 11 – two doses six to 12 months apart. The virus is a sexually transmitted infection. Although it appears to be vaccinated at a young age, the body has proven to have the highest immune response at the time. “So before we got this vaccine, 4,000 women in our country died of cervical cancer every year, and that’s completely preventable at this point. And so that’s what we should be doing,” Myers said. In Kansas and Missouri, more than half of teens have received a dose of the HPV vaccine. Only a third received both. Myers said it’s important to get fully vaccinated. The vaccine is actually approved up to the age of 45. But from the age of 15, three doses are needed instead of two. “It’s not about sexual transmission at all. It’s about preventing cancer later in life.” Myers said. All vaccination coverage fell during the pandemic when in-person doctor visits were limited. Myers said it’s important to keep those up to date. She said parents should make it a priority.

A vaccine to protect against some cancers has been shown to be very effective. The human papillomavirus vaccine recommended for pre-teens has been linked to a greater than 80% decrease in infections. A Kansas City doctor says that’s huge when it comes to saving lives.

The HPV vaccine was approved 15 years ago. Now a 10-year study shows the effect it has on the protection of children into adulthood. It reduces the transmission of the virus by as much as 88%. A virus linked to cervical cancer in women and throat cancer in men.

“I think people have really realized that the vaccine is safe, that the protection is phenomenal and that the side effects of this vaccine are really very minimal,” said Dr. Angela Myers, director of infectious diseases at Children’s Mercy Hospital.

The HPV vaccine is recommended for boys and girls at the age of 11 – two doses six to 12 months apart.

The virus is a sexually transmitted infection. Although it appears to be vaccinated at a young age, the body has proven to have the highest immune response at the time.

“So before we got this vaccine, 4,000 women in our country died of cervical cancer every year, and that’s completely preventable at this point. So that’s what we should be doing,” Myers said.

In Kansas and Missouri, more than half of teens have received one dose of the HPV vaccine. Only a third received both. Myers said it’s important to get fully vaccinated.

The vaccine is actually approved up to the age of 45. But from the age of 15, it needs three doses instead of two.

“It’s not about sexual transmission at all. It’s about preventing cancer later in life,” said Myers.

All vaccination coverage fell during the pandemic when visits to in-person doctors were limited. Myers said it is important to keep them informed. She said parents should make it a priority.

Comments are closed.